Equifax (NYSE:EFX) had its target price hoisted by Morgan Stanley from $115.00 to $129.00 in a research report report published on Friday morning, BenzingaRatingsTable reports. Morgan Stanley currently has an equal weight rating on the credit services provider’s stock.
A number of other research analysts have also recently weighed in on EFX. ValuEngine cut shares of Zynerba Pharmaceuticals from a buy rating to a hold rating in a research note on Tuesday, May 28th. Deutsche Bank reiterated a hold rating on shares of United Parcel Service in a research note on Tuesday, July 2nd. Barclays boosted their price target on shares of WEX from $222.00 to $238.00 and gave the stock an overweight rating in a research note on Monday, May 6th. Royal Bank of Canada set a $184.00 price target on shares of Jazz Pharmaceuticals and gave the stock a buy rating in a research note on Wednesday, July 3rd. Finally, Zacks Investment Research cut shares of HEXO from a hold rating to a sell rating in a research note on Wednesday, May 15th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating to the stock. The stock currently has an average rating of Hold and an average price target of $126.00.
NYSE:EFX opened at $137.84 on Friday. The stock has a 50 day moving average of $134.10. The company has a market cap of $16.59 billion, a P/E ratio of 23.81, a PEG ratio of 2.85 and a beta of 1.24. Equifax has a 12 month low of $88.68 and a 12 month high of $140.52. The company has a debt-to-equity ratio of 1.02, a quick ratio of 0.57 and a current ratio of 0.57.
Large investors have recently modified their holdings of the stock. Deroy & Devereaux Private Investment Counsel Inc. acquired a new position in Equifax during the 2nd quarter valued at approximately $216,000. Bessemer Group Inc. increased its stake in shares of Equifax by 101,464.1% in the second quarter. Bessemer Group Inc. now owns 404,225 shares of the credit services provider’s stock worth $54,669,000 after acquiring an additional 403,827 shares during the period. Livforsakringsbolaget Skandia Omsesidigt increased its stake in shares of Equifax by 58.0% in the second quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,635 shares of the credit services provider’s stock worth $221,000 after acquiring an additional 600 shares during the period. NuWave Investment Management LLC increased its stake in shares of Equifax by 933.3% in the second quarter. NuWave Investment Management LLC now owns 186 shares of the credit services provider’s stock worth $25,000 after acquiring an additional 168 shares during the period. Finally, Oakbrook Investments LLC increased its stake in shares of Equifax by 3.1% in the second quarter. Oakbrook Investments LLC now owns 6,312 shares of the credit services provider’s stock worth $854,000 after acquiring an additional 190 shares during the period. Institutional investors own 94.43% of the company’s stock.
Equifax Inc provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers. The company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions, and Global Consumer Solutions. The USIS segment offers consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting; mortgage loan origination information; financial marketing; and identity management services.
Featured Story: What is a capital gains distribution?
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.